EULAV Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

EULAV Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-135,084	Closed	-$8.53M	–	224
2021 Q1	$8.53M	Sell	135,084 -19,994	-13%	-$1.24M	0.23%	111
2020 Q4	$9.62M	Sell	155,078 -19,922	-11%	-$1.23M	0.25%	113
2020 Q3	$10.6M	Sell	175,000 -15,044	-8%	-$905K	0.31%	100
2020 Q2	$11.2M	Buy	190,044 +119,990	+171%	+$7.18M	0.37%	92
2020 Q1	$3.9M	Sell	70,054 -14,946	-18%	-$914K	0.16%	140
2019 Q4	$5.46M	Sell	85,000 -3,000	-3%	-$172K	0.19%	129
2019 Q3	$4.46M	Sell	88,000 -12,000	-12%	-$564K	0.16%	144
2019 Q2	$4.54M	Buy	100,000 +30,000	+43%	+$1.4M	0.17%	143
2019 Q1	$3.3M	Buy	+70,000	New	+$3.49M	0.14%	163
2015 Q4	–	Sell	-22,400	Closed	-$1.33M	–	297
2015 Q3	$1.33M	Hold	22,400	–	–	0.08%	248
2015 Q2	$1.49M	Hold	22,400	–	–	0.08%	258
2015 Q1	$1.45M	Hold	22,400	–	–	0.07%	266
2014 Q4	$1.32M	Hold	22,400	–	–	0.07%	276
2014 Q3	$1.15M	Hold	22,400	–	–	0.06%	293
2014 Q2	$1.09M	Sell	22,400 -45,000	-67%	-$2.22M	0.06%	315
2014 Q1	$3.5M	Hold	67,400	–	–	0.19%	171
2013 Q4	$3.58M	Hold	67,400	–	–	0.2%	173
2013 Q3	$3.12M	Sell	67,400 -600	-0.9%	-$26.3K	0.18%	181
2013 Q2	$3.04M	Buy	+68,000	New	+$2.95M	0.19%	186

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

EULAV Asset Management's BMY Position: Q2 2021 in Review

EULAV Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 135,084 shares — an estimated $8.53M sold.

EULAV Asset Management first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $11.2M in Q2 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

EULAV Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
EULAV Asset Management sold 135,084 Bristol-Myers Squibb shares in Q2 2021, an estimated $8.53M.
EULAV Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
EULAV Asset Management's Bristol-Myers Squibb position peaked at $11.2M in Q2 2020.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on EULAV Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.